Yumin Ke

540 total citations
28 papers, 304 citations indexed

About

Yumin Ke is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Yumin Ke has authored 28 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Obstetrics and Gynecology, 9 papers in Reproductive Medicine and 8 papers in Molecular Biology. Recurrent topics in Yumin Ke's work include Endometrial and Cervical Cancer Treatments (7 papers), Ovarian cancer diagnosis and treatment (7 papers) and Cancer-related molecular mechanisms research (5 papers). Yumin Ke is often cited by papers focused on Endometrial and Cervical Cancer Treatments (7 papers), Ovarian cancer diagnosis and treatment (7 papers) and Cancer-related molecular mechanisms research (5 papers). Yumin Ke collaborates with scholars based in China, Taiwan and Malaysia. Yumin Ke's co-authors include J S Rhim, C C Harris, Louise Malan‐Shibley, Roger R. Reddel, M. Edward Kaighn, J.F. Lechner, Tsing‐Fen Ho, Chien‐Hsing Lu, Yung‐Sheng Lin and Min‐Min Chou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Experimental Cell Research.

In The Last Decade

Yumin Ke

25 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yumin Ke China 10 140 55 54 40 30 28 304
So Jung Kim South Korea 11 243 1.7× 44 0.8× 88 1.6× 25 0.6× 63 2.1× 33 520
Zhongxun Li China 8 161 1.1× 29 0.5× 19 0.4× 103 2.6× 16 0.5× 12 268
Na Hao China 11 146 1.0× 39 0.7× 56 1.0× 68 1.7× 32 1.1× 45 459
Eiji Nishio Japan 10 79 0.6× 45 0.8× 33 0.6× 76 1.9× 72 2.4× 29 300
Eikan Koh Japan 8 124 0.9× 23 0.4× 91 1.7× 14 0.3× 19 0.6× 12 402
Jeremy D. Ward United States 9 148 1.1× 14 0.3× 23 0.4× 51 1.3× 45 1.5× 14 310
She‐Hung Chan Taiwan 13 170 1.2× 20 0.4× 18 0.3× 20 0.5× 26 0.9× 25 334
Irene Aguilera‐Barrantes United States 8 133 0.9× 96 1.7× 33 0.6× 93 2.3× 40 1.3× 14 315
Antonella Vardeu United Kingdom 8 134 1.0× 48 0.9× 112 2.1× 44 1.1× 17 0.6× 11 427
Annika Vienonen Finland 9 104 0.7× 53 1.0× 47 0.9× 26 0.7× 37 1.2× 9 402

Countries citing papers authored by Yumin Ke

Since Specialization
Citations

This map shows the geographic impact of Yumin Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumin Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumin Ke more than expected).

Fields of papers citing papers by Yumin Ke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumin Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumin Ke. The network helps show where Yumin Ke may publish in the future.

Co-authorship network of co-authors of Yumin Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Yumin Ke. A scholar is included among the top collaborators of Yumin Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yumin Ke. Yumin Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Shiying, et al.. (2025). Identification of the key immune gene NR3C1 as a diagnostic biomarker in differentiating ovarian borderline tumors from benign tumors. Frontiers in Cell and Developmental Biology. 13. 1602192–1602192.
2.
Huang, Li, et al.. (2025). LYN and CYBB are pivotal immune and inflammatory genes as diagnostic biomarkers in recurrent spontaneous abortion. Frontiers in Immunology. 16. 1568536–1568536.
3.
Sheng, Liying, et al.. (2024). Identification of an inflammatory response-related gene prognostic signature and immune microenvironment for cervical cancer. Frontiers in Molecular Biosciences. 11. 1394902–1394902. 3 indexed citations
4.
Chen, Shiying, et al.. (2024). Advances in understanding the molecular mechanisms of borderline ovarian tumors. Frontiers in Molecular Biosciences. 11. 1429852–1429852. 1 indexed citations
5.
Sheng, Liying, et al.. (2023). A novel immune-related risk-scoring system associated with the prognosis and response of cervical cancer patients treated with radiation therapy. Frontiers in Molecular Biosciences. 10. 1297774–1297774. 1 indexed citations
6.
Ke, Yumin, et al.. (2023). Association of the LEP gene with immune infiltration as a diagnostic biomarker in preeclampsia. Frontiers in Molecular Biosciences. 10. 1209144–1209144. 7 indexed citations
7.
Huang, Fang, et al.. (2023). The Diagnosis and Treatment of Caesarean Scar Defect: Progress and Controversies. SHILAP Revista de lepidopterología. 50(6).
8.
Ke, Yumin, et al.. (2022). Combination of Estrogen Receptor Alpha and Histological Type Helps to Predict Lymph Node Metastasis in Patients with Stage IA2 to IIA2 Cervical Cancer. SHILAP Revista de lepidopterología. 2 indexed citations
9.
Ke, Yumin, et al.. (2022). Identificationof core genes shared by endometrial cancer and ovarian cancer using an integrated approach. Cellular and Molecular Biology. 68(9). 140–145. 7 indexed citations
10.
Ke, Yumin, et al.. (2022). DPP6 and MFAP5 are associated with immune infiltration as diagnostic biomarkers in distinguishing uterine leiomyosarcoma from leiomyoma. Frontiers in Oncology. 12. 1084192–1084192. 6 indexed citations
11.
Wu, Dandan, et al.. (2020). Long non-coding RNA GClnc1 knockdown suppresses progression of epithelial ovarian cancer by recruiting FOXC2 to disrupt the NOTCH1/NF-κB/Snail pathway. Experimental Cell Research. 399(1). 112422–112422. 11 indexed citations
12.
Ke, Yumin, et al.. (2019). Wogonoside inhibits tumor growth and metastasis in endometrial cancer via ER stress-Hippo signaling axis. Acta Biochimica et Biophysica Sinica. 51(11). 1096–1105. 12 indexed citations
14.
Chang, Ting‐Chang, Hung‐Chun Fu, Yumin Ke, et al.. (2016). Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer. Medicine. 95(15). e3330–e3330. 9 indexed citations
15.
Sun, Lou, Peng‐Hui Wang, Tsai‐Feng Fu, et al.. (2016). Clinical parameters associated with absence of endocervical/transformation zone component in conventional cervical Papanicolaou smears. Taiwanese Journal of Obstetrics and Gynecology. 55(1). 81–84. 2 indexed citations
16.
Chen, Minyu, Yumin Ke, Jen‐Ruei Chen, et al.. (2015). Outcome of ovarian preservation during surgical treatment for endometrial cancer: A Taiwanese Gynecologic Oncology Group study. Taiwanese Journal of Obstetrics and Gynecology. 54(5). 532–536. 7 indexed citations
17.
Ke, Yumin, et al.. (2015). Tanshinone IIA enhances the effects of TRAIL by downregulating survivin in human ovarian carcinoma cells. Phytomedicine. 22(10). 929–938. 23 indexed citations
18.
Hsu, Shih‐Tien, Ren‐Ching Wang, Chien‐Hsing Lu, et al.. (2013). Report of two cases of adenoid cystic carcinoma of Bartholin's gland and review of literature. Taiwanese Journal of Obstetrics and Gynecology. 52(1). 113–116. 18 indexed citations
19.
Chou, Min‐Min, et al.. (2010). Temporary Cross-clamping of the Infrarenal Abdominal Aorta During Cesarean Hysterectomy to Control Operative Blood Loss in Placenta Previa Increta/Percreta. Taiwanese Journal of Obstetrics and Gynecology. 49(1). 72–76. 17 indexed citations
20.
Liu, Fu-Shing, et al.. (2004). Management of Pelvic Lymphocysts by Ultrasound-Guided Aspiration and Minocycline Sclerotherapy. Gynecologic and Obstetric Investigation. 59(3). 130–133. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026